A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

645

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2006

Conditions
Psoriasis
Interventions
DRUG

Tacrolimus

Trial Locations (32)

10029

New York

14623

Rochester

19104

Philadelphia

20010

Washington D.C.

24501

Lynchburg

27157

Winston-Salem

30263

Newnan

33175

Miami

37203

Nashville

45219

Cincinnati

46617

South Bend

47713

Evansville

52242

Iowa City

53719

Madison

63117

St Louis

71913

Hot Springs

75230

Dallas

77555

Galveston

77802

Bryan

80501

Longmont

92117

San Diego

94118

San Francisco

97210

Portland

99328

Dayton

06511

New Haven

05401

Burlington

R3C 0N2

Winnipeg

A1B 4S8

St. John's

P1B 3Z7

North Bay

N2J 1C4

Waterloo

N8W 1E6

Windsor

S7N 0W8

Saskatoon

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY